Effect of the Japanese herbal medicine, Boiogito, on the osteoarthritis of the knee with joint effusion

Sports Medicine, Arthroscopy, Rehabilitation, Therapy and Technology

Volumn 4, Issue 1, 2012, Pages

  Majima, Tokifumi ^a   Inoue, Masahiro ^a   Kasahara, Yasuhiko ^a   Onodera, Tomohiro ^a   Takahashi, Daisuke ^a   Minami, Akio ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Boiogito; Japanese herbal medicine; Joint effusion; Osteoarthritis of the knee

Indexed keywords

ASTRAGALUS EXTRACT; ATRACTYLODES EXTRACT; BOIOGITO; GINGER EXTRACT; GLYCYRRHIZA EXTRACT; HERBACEOUS AGENT; JUJUBE EXTRACT; LOXOPROFEN; SINOMENINE; UNCLASSIFIED DRUG;

AGED; ARTICLE; CLIMBING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FUNCTIONAL SCORE; HERBAL MEDICINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; JOINT EFFUSION; KNEE OSTEOARTHRITIS; KNEE SCORE; KNEE SOCIETY RATING SYSTEM; MALE; QUALITY OF LIFE; SCORING SYSTEM; SHORT FORM 36; SYMPTOMATOLOGY; XEROSTOMIA;

EID: 84856708968     PISSN: None     EISSN: 17582555     Source Type: Journal    
DOI: 10.1186/1758-2555-4-3     Document Type: Article

References (18)

1. Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P. OARSI recommendations for the management of hip and knee osteoarthritis, Part I: Critical appraisal of existing treatment guidelines and systematic review of current research evidence. OsteoArthritis and Cartilage 2007, 15:981-1000. 10.1016/j.joca.2007.06.014, 17719803.
2. Pelletier JP, Yaron M, Haraoui B, Cohen P, Nahir MA, Choquette D, Wigler I, Rosner IA, Beaulieu AD. Efficacy and safety of diacerein in osteoarthritis of the knee: a double-blind, placebo-controlled trial. Arthritis Rheum 2000, 43(10):2339-48. 10.1002/1529-0131(200010)43:10<2339::AID-ANR23>3.0.CO;2-P, 11037895.
3. Dougados M, Nguyen M, Berdah L, Mazieres B, Vignon E, Lequesne M. Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial Evaluation of the Chondromodulating Effect of Diacerein in OA of the Hip. Arthritis Rheum 2001, 44(11):2539-47. 10.1002/1529-0131(200111)44:11<2539::AID-ART434>3.0.CO;2-T, 11710710.
4. Nguyen M, Dougados M, Berdah L, Amor B. Diacerein in the treatment of osteoarthritis of the hip. Arthritis Rheum 1994, 37(4):529-36. 10.1002/art.1780370413, 8147930.
5. Liu L, Resch K, Kaever V. Inhibition of lymphocyte proliferation by the anti-rheumatic drug sinomenine. Int J Immunopharmac 1994, 16:685-691.
6. Liu L, Riese J, Resch K, Kaever V. Impairment of macrophage eicosanoid and nitric oxide production by sinomenine, an alkaloid from Sinomenium acutum. Arznein forsch/Drug Res 1994, 44:1223-1226.
7. Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957, 16(4):494-502. 10.1136/ard.16.4.494, 1006995, 13498604.
8. Insall JN, Dorr LD, Scott RD, Scott WN. Rationale of the Knee Society clinical rating system. Clin Orthop Relat Res 1989, 248:13-4.
9. Moskowitz RW, Abramson SB, Berenbaum F, Simon LS, Hochberg M. Coxibs and NSAIDs - is the air any clearer?. Perspectives from the OARSI/International COX-2 Study Group Workshop 2007, Osteoarthritis Cartilage 2007, 15:849-856.
10. Chou R, Helfand M, Peterson K, Dana T, Roberts C. Comparative Effectiveness and Safety of Analgesics for Osteoarthritis. Comparative Effectiveness Revie No. 4. (Prepared by the Oregon Evidence-based Practice Center under Contract No. 290-02-0024)Rockville, MD: Agency for Healthcare Research and Quality Available at:www.effectivehealthcare.ahrq.gov/reports/final.cfm.
11. Mastbergen SC, Jansen NW, Bijlsma JW, Lafeber FP. Differential direct effects of cyclo-oxygenase-1/2 inhibition on proteoglycan turnover of human osteoarthritic cartilage: an in vitro study. Arthritis Research & Therapy 2006, 8(1):R2. 10.1186/ar1846, 22235253.
12. Smith RL, Kajiyama G, Lane NE. Nonsteroidal antiinflammatory drugs: effects on normal and interleukin 1 treated human articular chondrocyte metabolism in vitro. J Rheumatol 1995, 22:1130-1137.
13. Struglics A, Larsson S, Pratta MA, Kumar S, Lark MW, Lohmander LS. Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase and matrix metalloproteinase-generated aggrecan fragments. Osteoarthritis Cartilage 2006, 14(2):101-13. 10.1016/j.joca.2005.07.018, 16188468.
14. Salinardi BJ, Roush JK, Schermerhorn T, Mitchell KE. Matrix metalloproteinase and tissue inhibitor of metalloproteinase in serum and synovial fluid of osteoarthritic dogs. Vet Comp Orthop Traumatol 2006, 19(1):49-55.
15. Liu L, Buchner E, Beitze D, Schmid-Weber CB, Kaever V, Emmrich F, Kinne RW. Amelioration of rat experimental arthritides by treatment with the alkaloid sinomenine. International Journal of Immunopharmacology 1996, 18(10):529-543. 10.1016/S0192-0561(96)00025-2, 9080247.
16. Lee SJ, Oh SG, Seo SW, Ahn HJ, Geum D, Cho JJ, Park CS. Oral administration of Astragalus membranaceus inhibits the development of DNFB-induced dermatitis in NC/Nga mice. Biol Pharm Bull 2007, 30(8):1468-71. 10.1248/bpb.30.1468, 17666805.
17. Zhao P, Su G, Xiao X, Hao E, Zhu X, Ren J. Chinese medicinal herb Radix Astragali suppresses cardiac contractile dysfunction and inflammation in a rat model of autoimmune myocarditis. Toxicol Lett 2008, 182(1-3):29-35. 10.1016/j.toxlet.2008.08.002, 18782607.
18. Hoo RLC, Wong JYL, Qiao CF, Xu A, Xu HX, Lam KSL. The effective fraction isolated from Radix Astragali alleviates glucose intolerance, insulin resistance and hypertriglyceridemia in db/db diabetic mice through its anti-inflammatory activity. Nutrition & Metabolism 2010, 7:67-79.